statistiche ricercatore

Continente	#
NA - Nord America	1.120
AS - Asia	535
EU - Europa	431
SA - Sud America	84
AF - Africa	19
Continente sconosciuto - Info sul continente non disponibili	18
OC - Oceania	1
Totale	2.208

Nazione	#
US - Stati Uniti d'America	1.075
SG - Singapore	213
CN - Cina	108
IT - Italia	87
SE - Svezia	73
BR - Brasile	63
GB - Regno Unito	62
DE - Germania	57
VN - Vietnam	57
HK - Hong Kong	51
FI - Finlandia	44
RU - Federazione Russa	28
CA - Canada	25
FR - Francia	22
KR - Corea	17
BD - Bangladesh	15
ID - Indonesia	14
IN - India	13
PL - Polonia	11
MX - Messico	10
NL - Olanda	9
BG - Bulgaria	8
AR - Argentina	6
AT - Austria	6
MA - Marocco	6
MY - Malesia	6
SI - Slovenia	6
ZA - Sudafrica	6
JP - Giappone	5
PH - Filippine	5
IQ - Iraq	4
LT - Lituania	4
SA - Arabia Saudita	4
TR - Turchia	4
UZ - Uzbekistan	4
VE - Venezuela	4
BE - Belgio	3
CO - Colombia	3
IR - Iran	3
JO - Giordania	3
PY - Paraguay	3
CL - Cile	2
CZ - Repubblica Ceca	2
DZ - Algeria	2
KE - Kenya	2
NI - Nicaragua	2
NP - Nepal	2
PK - Pakistan	2
RS - Serbia	2
SV - El Salvador	2
TN - Tunisia	2
AD - Andorra	1
AE - Emirati Arabi Uniti	1
AG - Antigua e Barbuda	1
AZ - Azerbaigian	1
BO - Bolivia	1
CR - Costa Rica	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
ES - Italia	1
ET - Etiopia	1
GT - Guatemala	1
IE - Irlanda	1
JM - Giamaica	1
LA - Repubblica Popolare Democratica del Laos	1
MD - Moldavia	1
NZ - Nuova Zelanda	1
PA - Panama	1
PE - Perù	1
PT - Portogallo	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
UA - Ucraina	1
Totale	2.190

Nome	#
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study	384
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison	286
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART	271
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering	255
Evaluation of HIV transmission clusters among natives and foreigners living in Italy	232
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort	202
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy	198
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART	193
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME	187
Totale	2.208

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	162	0	0	23	11	8	9	12	15	16	11	32	25
2022/2023	285	38	41	19	23	40	24	14	27	21	0	14	24
2023/2024	134	5	10	12	15	32	16	12	8	2	3	5	14
2024/2025	477	17	6	5	42	75	73	44	19	60	23	44	69
2025/2026	779	63	31	40	97	159	54	107	29	68	71	23	37
2026/2027	47	12	35	0	0	0	0	0	0	0	0	0	0
Totale													2.208